Precision Medicine Platforms
Part of Healthcare - Genomics & Precision Medicine
| Ticker | Company | Mkt Cap▼ | Price | Chg% | Volume |
|---|---|---|---|---|---|
 AZN | AstraZeneca PLC | $300.7b | $190.00 | -1.2% | 2.4M |
 TMO | Thermo Fisher Scientific, Inc. | $178.3b | $467.89 | +0.3% | 2.7M |
 DHR | Danaher Corporation | $130.1b | $177.65 | -0.5% | 6.4M |
 WAT | Waters Corp | $28.8b | $308.88 | -0.7% | 869.8K |
 BBIO | BridgeBio Pharma, Inc. Common Stock | $13.4b | $73.28 | +2.2% | 4.1M |
 GH | Guardant Health, Inc. Common Stock | $11.3b | $88.89 | +1.2% | 1.2M |
 RVTY | Revvity, Inc. | $9.5b | $86.77 | -0.4% | 1.2M |
 TECH | Bio-Techne Corp. | $8.1b | $54.19 | +3.8% | 2.0M |
 PRAX | Praxis Precision Medicines, Inc. Common Stock | $7.7b | $344.83 | +4.6% | 345.9K |
 NUVL | Nuvalent, Inc. Class A Common Stock | $7.6b | $104.50 | -3.3% | 993.5K |
 TEM | Tempus AI, Inc. Class A Common Stock | $7.6b | $52.20 | +1.5% | 3.8M |
 KYMR | Kymera Therapeutics, Inc. Common Stock | $6.5b | $84.92 | -2.6% | 393.7K |
 CAI | Caris Life Sciences, Inc. Common Stock | $4.8b | $20.21 | +2.1% | 830.4K |
 LNTH | Lantheus Holdings, Inc | $4.8b | $84.35 | +1.8% | 476.5K |
 DYN | Dyne Therapeutics, Inc. Common Stock | $2.8b | $18.28 | -3.3% | 1.2M |
 IDYA | IDEAYA Biosciences, Inc. Common Stock | $2.8b | $30.73 | +0.1% | 649.1K |
 TWST | Twist Bioscience Corporation Common Stock | $2.7b | $60.95 | +3.6% | 945.4K |
 ADPT | Adaptive Biotechnologies Corporation Common Stock | $2.0b | $14.15 | +2.4% | 876.1K |
 WGS | GeneDx Holdings Corp. Class A Common Stock | $1.7b | $68.46 | +3.4% | 457.2K |
 MAZE | Maze Therapeutics, Inc. Common Stock | $1.4b | $25.82 | -0.7% | 504.0K |
 CDNA | CareDx, Inc. | $0.8b | $21.23 | +5.8% | 570.7K |
 CSTL | Castle Biosciences, Inc. Common Stock | $0.7b | $24.47 | +3.3% | 341.4K |
 ANRO | Alto Neuroscience Inc. | $0.6b | $24.40 | -5.1% | 195.0K |
 CTKB | Cytek Biosciences, Inc. Common Stock | $0.6b | $4.39 | +3.1% | 577.7K |
 NAUT | Nautilus Biotechnolgy, Inc. Common Stock | $434.1m | $2.62 | +1.6% | 286.7K |
 AURA | Aura Biosciences, Inc. Common Stock | $394.2m | $7.30 | +0.6% | 299.5K |
 LAB | Standard BioTools Inc. Common Stock | $359.5m | $0.90 | +0.4% | 1.6M |
 SOPH | SOPHiA GENETICS SA Ordinary Shares | $336.1m | $4.85 | -0.4% | 46.8K |
 AVXL | Anavex Life Sciences | $261.3m | $3.35 | +1.2% | 617.6K |
 ACIU | AC Immune SA | $260.5m | $2.85 | -4.0% | 144.6K |
 FHTX | Foghorn Therapeutics Inc. Common Stock | $259.5m | $5.31 | +2.3% | 81.1K |
 OABI | OmniAb, Inc. Common Stock | $225.9m | $1.46 | -6.4% | 463.8K |
 NVCT | Nuvectis Pharma, Inc. Common Stock | $198.4m | $8.89 | +1.2% | 72.1K |
 PRLD | Prelude Therapeutics Incorporated | $193.4m | $4.70 | +6.7% | 865.2K |
 QTRX | Quanterix Corporation Common Stock | $161.0m | $3.27 | +3.5% | 713.3K |
 QSI | Quantum-Si Incorporated Class A Common Stock | $159.6m | $0.91 | -3.5% | 7.3M |
 BDSX | Biodesix, Inc. Common Stock | $135.9m | $10.68 | +7.2% | 49.5K |
 MDXH | MDxHealth SA Ordinary Shares | $117.6m | $2.08 | -4.2% | 105.4K |
 SEER | Seer, Inc. Class A Common Stock | $94.8m | $1.96 | +1.0% | 1.1M |
 CSBR | Champions Oncology, Inc. | $81.1m | $6.01 | -0.5% | 1.5K |
 SERA | Sera Prognostics, Inc. Class A Common Stock | $75.2m | $2.06 | -2.8% | 20.1K |
 XGN | Exagen Inc. Common Stock | $63.7m | $2.71 | +0.9% | 85.9K |
 IBIO | iBio, Inc. Common Stock | $59.1m | $1.67 | -7.7% | 1.2M |
 ACRV | Acrivon Therapeutics, Inc. Common Stock | $50.0m | $1.93 | +2.1% | 413.9K |
 CCEL | Cryo-Cell International Inc. | $27.5m | $3.67 | -6.1% | 8.5K |
 TVGN | Tevogen Bio Holdings Inc. Common Stock | $17.4m | $7.61 | +8.6% | 11.7K |
 ALLR | Allarity Therapeutics, Inc. Common Stock | $16.7m | $1.33 | -4.6% | 92.0K |
 ADVB | Advanced Biomed Inc. Common Stock | $6.1m | $5.75 | -11.1% | 42.0K |
 CDIO | Cardio Diagnostics Holdings Inc. Common stock | $5.1m | $1.83 | +0.5% | 30.7K |